Slide 1

News

VPM is now Serum Life Science Europe

We are thrilled to share an exciting update with you. After a period of thoughtful consideration, we are proud to announce that our company name, formerly Vakzine Projekt Management GmbH (VPM), has been changed to Serum Life Science Europe GmbH (SLS Europe).

READ MORE

News & Events

REGISTRATION IS OPEN!

It is our pleasure to announce that the 14th International VPM Days will take place on Thursday and Friday, 28 and 29 September 2023 at TWINCORE in Hannover, Germany.

rEGISTER HERE >
READ MORE
Slide 2

NEWS

VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG

Press

Results of SAKK 06/14 trial with VPM1002BC

The phase I/II clinical trial data with VPM1002BC, a genetically modified bacillus Calmette-Guérin (BCG) strain, has been published in European Urology Oncology. Even three years after the treatment start, almost half of the patients remained recurrence-free. We thank all patients, colleagues, and collaborators for their contributions.

Read more
Slide 3

A competent partner at your side

Free first consulting session

We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.

send us an e-mail >

From Bench to Product

Consulting and services

Slide 4

A competent partner at your side

Free first consulting session

From Bench to Product

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our services >
previous arrowprevious arrow
next arrownext arrow

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

News & Press

VPM is now Serum Life Science Europe

News

We are thrilled to share an exciting update with you. After a period of thoughtful consideration, we are proud to announce that our company name, formerly Vakzine Projekt Management GmbH (VPM), has been changed to Serum Life Science Europe GmbH (SLS Europe).

07.09.2023

Stefan Kaufmann Advocates for Advancements in Tuberculosis Control

News

Renowned vaccine researcher, Prof. Dr. Stefan H. E. Kaufmann, recently shared his expertise and insights on tuberculosis in an exclusive interview with ETHealthworld. Prof. Dr. Kaufmann, the inventor of VPM1002, highlighted the urgent need for better TB vaccines and advancements in novel drug regimens to combat this global health challenge.Here is the link to his interview.

We are honored to introduce Prof. Dr. Kaufmann as the keynote lecturer at the 14th International VPM Days, taking place on September 28th and 29th at TWINCORE in Hannover. This event serves as a unique opportunity to learn from one of the foremost experts in the field and connect with like-minded professionals and researchers.

Register now via email to:VPMDays2023@vakzine-manager.de to secure your spot.

02.08.2023

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.

Scroll to Top